Try our Advanced Search for more refined results
September 07, 2018
BioDelivery Sciences International, Inc. et al v. Alvogen Pb Research & Development LLC et al
Case Number:
1:18-cv-01395
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 20, 2021
Del. Judge Upholds Claims In Opioid Drug IP But Axes Others
A Delaware federal judge on Monday upheld claims in two patents that BioDelivery Sciences International Inc. accused Alvogen PB Research and Development LLC of infringing with a planned generic of the opioid pain medication Belbuca, but invalidated claims in a third.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login